Passengers who have had a positive viral test in the past 3 months (or the time period specified in CDC guidance) and have met the criteria to discontinue isolation may travel with documentation of recovery from COVID-19. For those who are not fully vaccinated, this test must be conducted no more than 1 day before their flight’s departure. For those who are fully vaccinated, this test must be conducted no more than 3 days before their flight’s departure. citizens and those who are fully vaccinated, to present a negative COVID-19 test result from a nucleic acid amplification test (NAAT) or antigen test (“viral test”). Predeparture Testing Requirement for International Air Passengers Traveling to the United StatesĬDC issued an Order (amended October 25, 2021) that requires all air passengers aged two years and older coming to the United States, including U.S. See more information about this requirement. Travelers are not required to wear a mask in outdoor areas of a conveyance (like a ferry or top deck of a bus). transportation hubs such as airports and stations. Mask RequirementĪs of February 2, 2021, CDC requires wearing masks on planes, buses, trains, and other forms of public transportation traveling into, within, or out of the United States and while indoors at U.S. jurisdiction after international or domestic travel. Travelers should additionally follow guidance and requirements of destination countries for international travel, or state, tribal, local, and territorial authorities when arriving in a U.S. Health departments have the authority to take actions that exceed CDC recommendations in their jurisdictions. Requirements, Recommendations, and ConsiderationsĬDC’s requirements and recommendations for public health management of international and domestic travelers are provided below. public health officials with an overview of CDC’s requirements, recommendations, and considerations for management of vaccinated and unvaccinated domestic and international travelers.
#EMERGENCY 4 LA MOD SUPERVISOR SERIES#
People are considered fully vaccinated for COVID-19 ≥2 weeks after they have received the second dose in a 2-dose series (Pfizer-BioNTech or Moderna) or ≥2 weeks after they have received a single-dose of the Johnson & Johnson /Janssen vaccine. However, global circulation of SARS-CoV-2 variants of concern, variants being monitored, vaccine performance against emerging variants, and global vaccination coverage remain concerns. Travel-associated transmission risk substantially reduced among those fully vaccinated. CDC has issued requirements and recommendations to prevent travel-associated exposure to and transmission of SARS-CoV-2.Īs vaccination efforts continue across the United States and internationally, the proportion of travelers who are fully vaccinated will continue to increase. Travelers should also take recommended precautions to limit community spread after traveling from one location to another.
communities, all travelers should remain vigilant for signs and symptoms of COVID-19. This could result in travelers spreading the virus to others at their destinations or upon returning home.Īs part of a broader strategy aimed to limit continued new introduction of SARS-CoV-2 and the emergence of new SARS-CoV-2 variants in U.S. Individuals who travel may be at risk for exposure to SARS-CoV-2, the virus that causes COVID-19, before, during, or after travel.
0 kommentar(er)
